|
|
| Model Number |
44312 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
02/22/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Batch records showed no signs of deviations.There is no previous complaint reported on the same lot.Complaint report included statements device was not suspected to be deficient.The used device was discarded and not returned.The returned unused catheters (surrogate devices) from the same lot and customer box were investigated with results as follows: visual inspection showed no signs of defects or deviations.Tests of coating sliperiness and coating friction, respectively, gave both results within specification limits.Instructions for use informs about the risk of bleedings in relation to urinary catheterisation therapy.Urethral damage is a known common adverse event for the therapy and specified in instructions for use.No root cause identified related to the device.The most probably root cause is considered to be related to the user concomitantly treated with anticoagulant therapy thereby being predisposed to bleeding more easily and severely if experiencing urethral damage.Further, as verified by clinical urology experts consulted during investigation of this case, urethral trauma with bleeding is a known risk during intermittent catheterisation (ic), which normally is mild and transient without medical intervention.In patients treated with anticoagulants (ac) the risk of prolonged bleeding is increased, which is well known by both the patients and healthcare professionals.Ic using atraumatic, hydrophilic catheters such as the device in question minimizes the risk of urethral trauma and bleeding.Patients in need of bladder management can often be on life-long treatment with ac, and the risk of prolonged bleeding is outweighed by the benefits of ic using hydrophilic catheters.
|
| |
|
Event or Problem Description
|
|
Event occured in (b)(6), i.E.Outside usa.According to complaint reporter, the patient begun performing intermittent catheterization therapy, after training by healthcare professional on (b)(6) 2020 and without problems the first days at home.The patient, who is concomitantly treated with anticoagulant therapy, noticed a bleeding ((b)(6)) and on the day after he also noticed blood lumps in urine.When withdrawing a catheter on the same day a more severe bleeding developed.The patient visited his urologist to following day ((b)(6)).The urologist inserted an indwelling catheter and urinary collection bag.The bleeding developed more severely over night and the user was admitted to hospital ((b)(6)).The bleeding stopped.Patient was treated with antibiotics.Surgery is planned for the patient, to enable bladder management by other means than intermittent catheterization.The patient had reported he did not suspect any device deficiency.
|
| |
|
Search Alerts/Recalls
|
|
|